Dr. Shrikanth Atluri
Surgical Oncologist
Urological Cancers
MBBS, MS General Surgery, MCh Urology
- Experience
- 14+ years
- Speaks
- English · Hindi · Telugu · Marathi
Cancers treated
- Urological
About Dr. Shrikanth Atluri
Dr. Shrikanth Atluri is a uro-oncologist who specialises in robotic and minimally invasive surgery for kidney, prostate, bladder, adrenal, penile and testicular cancers. Dr. Atluri trained at Tata Memorial Hospital and the University of Miami, with fellowship training in laparoscopic and robotic urology.
Treatments offered
Urological
- Robotic partial & radical nephrectomy
- Robotic radical prostatectomy (nerve-sparing)
- Robotic cystectomy
- Laparoscopic urological surgery
- Minimally invasive adrenal surgery
Career
- SSO Hospitals (Ghatkopar, Charni Road), MumbaiUro-oncologist & robotic surgeon · 2023–Present
- Sir H. N. Reliance Foundation Hospital, MumbaiConsultant Uro-Oncologist and Robotic Surgeon · 2021–Present
- Tata Memorial Hospital, MumbaiSpecialist Senior Registrar, Department of Uro-oncology · 2016–2017
Education & Training
- Fellowship, Laparoscopic and Robotic UrologyUniversity of Miami Hospital, USA · 2021
- Fellowship, Urologic OncologyUniversity of Miami Hospital, USA · 2018–2020
- Fellowship, Urologic OncologyTata Memorial Hospital · 2017–2018
- MCh, UrologyBombay Hospital Institute of Medical Sciences, Mumbai · 2016
- MS, General SurgerySeth G.S. Medical College & KEM Hospital, Mumbai · 2012
- MBBSB.J. Government Medical College, Pune (MUHS) · 2009
Research & Publications
See publications on PubMed (opens in a new tab)
Reviews & guidelines
- 2022Focal therapy for localized prostate cancer - Current status (opens in a new tab)Indian J Urol
- 2021Serum and urine biomarkers for detecting clinically significant prostate cancer (opens in a new tab)Urol Oncol
- 2019Serum and urinary biomarkers for detection and active surveillance of prostate cancer (opens in a new tab)Curr Opin Urol
Co-authored
- 2025Exceptional Response to Immunotherapy-based Treatment in Compound EGFR-Mutated Oligometastatic Pulmonary Sarcomatoid Carcinoma: A Case Report (opens in a new tab)J Immunother Precis Oncol
- 2023A multi-institutional study of 1,111 men with 4K score, multiparametric magnetic resonance imaging, and prostate biopsy (opens in a new tab)Urol Oncol
- 2020Reply by Authors (opens in a new tab)J Urol
- 2020Use and Validation of the AUA/SUO Risk Grouping for Nonmuscle Invasive Bladder Cancer in a Contemporary Cohort (opens in a new tab)J Urol